1.
Tadayasu Y, Sarashina A, Tsuda Y, Tatami S, Friedrich C, Retlich S, et al. Population Pharmacokinetic/Pharmacodynamic Analysis of the DPP-4 Inhibitor Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus. J Pharm Pharm Sci [Internet]. 2013 Dec. 17 [cited 2024 Nov. 21];16(5):708-21. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/20477